关于自然产品调节帕金森病肠道微生物群的研究进展
Ying Jia1, Yuanyuan Zhang2, Xin Tai3
1The Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in pharmacology
|September 24, 2025
概括
天然产品通过准肠道微生物群-代谢物轴,对帕金森病 (PD) 是有前途的. 与传统的PD治疗相比,这种方法提供了一个更安全,多目标的策略.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 涉及α-synuclein病理和多巴胺能神经元损失.
- 肠道微生物群失生症越来越多地与PD的发病和进展有关.
- 肠道微生物通过α-synuclein,肠脑屏障完整性,炎症和神经元损伤影响PD.
研究的目的:
- 为PD干预审查调节肠道微生物群的天然产品.
- 分析自然产品影响PD的具体机制.
- 为开发新型,安全的PD疗法提供理论基础.
主要方法:
- 关于天然产品及其对PD肠道微生物群的影响的综合文献综述.
- 分析涉及肠道微生物群-代谢物轴的机械路径.
- 评估自然产品的多目标协同监管和安全概况.
主要成果:
- 天然产品在传统的PD药物上具有优势,因为它们的多目标作用和安全性.
- 针对肠道微生物群-代谢物轴是PD干预的一个有希望的策略.
- 自然产品可以通过各种机制调节PD病理特征.
结论:
- 天然产品代表了帕金森病的可行的治疗策略.
- 通过天然产品调节肠道微生物群为PD治疗提供了一种新的方法.
- 对天然产品的进一步研究可以导致更安全,更有效的PD治疗方法.
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986

